Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 3376 AL 3390

Huntington disease like 2 (HDL-2) with parkinsonism and abnormal DAT-SPECT - A novel observation

Mulroy E, Latorre A, Menozzi E, Teh PC, Magrinelli F, Bhatia KP.

Parkinsonism Relat Disord. 2020 Feb;71:46-48. doi: 10.1016/j.parkreldis.2020.01.008. Epub 2020 Jan 16.

Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease

Martinez-Horta S, Horta-Barba A, Perez-Perez J, Sampedro F, de Lucia N, De Michele G, Kehrer S, Priller J, Migliore S, Squitieri F, Castaldo A, Mariotti C, Mañanes V, Lopez-Sendon JL, Rodriguez N, Martinez-Descals A, Garcia-Ruiz P, Júlio F, Januário C, Delussi M, de Tommaso M, Noguera S, Ruiz-Idiago J, Sitek EJ, Nuzzi A, Pagonabarraga J, Kulisevsky J; Cognitive Phenotype Working Group of the European Huntington’s Disease Network.

J Neurol. 2020 May;267(5):1527-1535. doi: 10.1007/s00415-020-09730-6. Epub 2020 Feb 7.

Natural and synthetic drugs used for the treatment of the dementia

Dembitsky VM, Dzhemileva L, Gloriozova T, D'yakonov V.

Biochem Biophys Res Commun. 2020 Apr 9;524(3):772-783. doi: 10.1016/j.bbrc.2020.01.123. Epub 2020 Feb 7.

Atypical presentation of acute rheumatic fever (ARF) in a 25-year-old woman in the Caribbean: a challenging diagnosis

Bordes SJ, Murray IVJ, Sylvester JA.

BMJ Case Rep. 2020 Feb 9;13(2):e231888. doi: 10.1136/bcr-2019-231888.

Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases

Novellino F, Saccà V, Donato A, Zaffino P, Spadea MF, Vismara M, Arcidiacono B, Malara N, Presta I, Donato G.

Int J Mol Sci. 2020 Feb 7;21(3):1115. doi: 10.3390/ijms21031115.

Gait variability as digital biomarker of disease severity in Huntington's disease

Gaßner H, Jensen D, Marxreiter F, Kletsch A, Bohlen S, Schubert R, Muratori LM, Eskofier B, Klucken J, Winkler J, Reilmann R, Kohl Z.

J Neurol. 2020 Jun;267(6):1594-1601. doi: 10.1007/s00415-020-09725-3. Epub 2020 Feb 11.

[Gene therapy for central nervous system disorders]

Nissen K, Klem L, Jeppesen R, Axelsen TM, Christiansen SH, Gøtzsche CR, Pinborg L, Jespersen B, Klemp K, Woldbye D.

Ugeskr Laeger. 2020 Jan 13;182(3):V09190535.

Hung-up Knee Jerk in Huntington's Disease

Fukumoto T, Miyamoto R.

N Engl J Med. 2020 Feb 13;382(7):e10. doi: 10.1056/NEJMicm1910309.

Identification of two compound heterozygous VPS13A large deletions in chorea-acanthocytosis only by protein and quantitative DNA analysis

Spieler D, Velayos-Baeza A, Mühlbäck A, Castrop F, Maegerlein C, Slotta-Huspenina J, Bader B, Haslinger B, Danek A.

Mol Genet Genomic Med. 2020 Sep;8(9):e1179. doi: 10.1002/mgg3.1179. Epub 2020 Feb 14.

Salivary Redox Biomarkers in Selected Neurodegenerative Diseases

Maciejczyk M, Zalewska A, Gerreth AK.

J Clin Med. 2020 Feb 12;9(2):497. doi: 10.3390/jcm9020497.

On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability

Khristich AN, Mirkin SM.

J Biol Chem. 2020 Mar 27;295(13):4134-4170. doi: 10.1074/jbc.REV119.007678. Epub 2020 Feb 14.

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders

Estrada JA, Contreras I.

Curr Neuropharmacol. 2020;18(8):769-787. doi: 10.2174/1570159X18666200217140255.

Imaging mass spectrometry allows for neuroanatomic-specific detection of gangliosides in the healthy and diseased brain

Wang WX , Whitehead SN .

Analyst. 2020 Apr 7;145(7):2473-2481. doi: 10.1039/c9an02270h. Epub 2020 Feb 17.

The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention

Elmatboly AM, Sherif AM, Deeb DA, Benmelouka A, Bin-Jumah MN, Aleya L, Abdel-Daim MM.

Environ Sci Pollut Res Int. 2020 Apr;27(11):11461-11483. doi: 10.1007/s11356-020-07914-1. Epub 2020 Feb 19.

Pridopidine in the treatment of Huntington's disease

Jabłońska M, Grzelakowska K, Wiśniewski B, Mazur E, Leis K, Gałązka P.

Rev Neurosci. 2020 May 26;31(4):441-451. doi: 10.1515/revneuro-2019-0085.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias